{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:38:42Z","timestamp":1768527522808,"version":"3.49.0"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) remains a significant and multifaceted challenge for modern healthcare. This issue becomes even more pressing during times of armed conflict and the subsequent recovery period, as research indicates an increased incidence of T2DM among combat veterans, largely due to post-traumatic stress disorder. Although numerous antidiabetic drugs are currently available, achieving optimal control of hyperglycemia continues to be problematic. In this context, and as part of a focused search for biologically active substances within the class of substituted and condensed [1,2,4]triazino[2,3-<jats:italic>c<\/jats:italic>]quinazolines, we explored the hypoglycemic effects of a newly synthesized series of such compounds. The study involved 21 synthesized compounds bearing the [1,2,4]triazino[2,3-<jats:italic>c<\/jats:italic>]quinazoline core. Experiments were conducted using white Wistar rats weighing between 260 and 280 grams. Prescreening of hypoglycemic activity was evaluated based on changes in blood glucose levels before and after compound administration by rats with normoglycemia. Compounds that demonstrated the most pronounced activity were selected for extended pharmacological evaluation using oral glucose tolerance test, adrenaline test, and rapid insulin tests in rats with dexamethasone-induced insulin resistance. Initial pharmacological screening under normoglycemic conditions showed that seven studied compounds significantly lowered blood glucose levels. Follow-up investigations validated the high hypoglycemic effect of 1,2,2-trimethyl-3-(3-methyl-2-oxo-2<jats:italic>H<\/jats:italic>- [1,2,4]triazino[2,3-<jats:italic>c<\/jats:italic>]quinazolin-6-yl)cyclopentane-1-carboxylic acid. Among the tested substances, compound 3-phenyl-6-(phenylamino)-2<jats:italic>H<\/jats:italic>-[1,2,4]triazino[2,3-<jats:italic>c<\/jats:italic>]quinazolin-2-one was the only one to exhibit moderate activity in the adrenaline tolerance test. None of the compounds enhanced insulin sensitivity in the liver or peripheral tissues. The findings suggest that substituted [1,2,4]triazino[2,3-<jats:italic>c<\/jats:italic>]quinazolines constitute a promising scaffold for the development of new hypoglycemic agents. 11\u03b2-Hydroxysteroid dehydrogenase is the most likely molecular target for lead-compound 1,2,2-trimethyl-3-(3-methyl-2-oxo-2<jats:italic>H<\/jats:italic>-[1,2,4]triazino[2,3-<jats:italic>c<\/jats:italic>]quinazolin-6-yl)cyclopentane-1-carboxylic acid.<\/jats:p>","DOI":"10.3389\/fendo.2025.1638013","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:12:12Z","timestamp":1758168732000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Future horizons in diabetes treatment: hypoglycemic activity of [1,2,4]triazino[2,3-c]quinazoline derivatives"],"prefix":"10.3389","volume":"16","author":[{"given":"Serhii","family":"Trzhetsynskyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Nosulenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kinichenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmytro","family":"Skoryna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halyna","family":"Berest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volodymyr","family":"Shvets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksii","family":"Voskoboinik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serhii","family":"Kovalenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavlo","family":"Petakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandr","family":"Kamyshnyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100459","DOI":"10.1016\/j.obmed.2022.100459","article-title":"Type 2 diabetes mellitus, its impact on quality of life and how the disease can be managed-a review","volume":"35","author":"Garg","year":"2022","journal-title":"Obes Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100193","DOI":"10.1016\/j.endmts.2024.100193","article-title":"Exploring the recent advancements and future prospects of personalized medicine in type 2 diabetes","volume":"16","author":"Nameghi","year":"2024","journal-title":"Endocrine Metab Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/genes16010107","article-title":"Gene therapy and diabetes: A narrative review of recent advances and the role of multidisciplinary healthcare teams","volume":"16","author":"Khartabil","year":"2025","journal-title":"Genes."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1363877","DOI":"10.3389\/fendo.2024.1363877","article-title":"Exploring the design of clinical research studies on the efficacy mechanisms in type 2 diabetes mellitus","volume":"15","author":"Guan","year":"2024","journal-title":"Front endocrinology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"103008","DOI":"10.1016\/j.eclinm.2024.103008","article-title":"The impact of war on people with type 2 diabetes in Ukraine: a survey study","volume":"79","author":"Sulaieva","year":"2025","journal-title":"eClinicalMedicine."},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1377\/hlthaff.2011.1150","article-title":"Confronting the urgent challenge of diabetes: an overview","volume":"31","author":"Fradkin","year":"2012","journal-title":"Health affairs (Project Hope)."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2004","article-title":"Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused","volume":"7","author":"Hossain","year":"2024","journal-title":"Health Sci Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3332\/ecancer.2020.1039","article-title":"The impact of armed conflict on cancer among civilian populations in low- and middle-income countries: a systematic review","volume":"14","author":"Jawad","year":"2020","journal-title":"Ecancermedicalscience."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057431","article-title":"Type 2 diabetes in Scottish military veterans: a retrospective cohort study","volume":"12","author":"Bergman","year":"2022","journal-title":"BMJ Open"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2196\/41933","article-title":"Challenges of type 2 diabetes mellitus management from the perspective of patients: conventional content analysis","volume":"11","author":"Nikpour","year":"2022","journal-title":"Interactive J Med Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2014.05.019","article-title":"Posttraumatic stress disorder and incidence of type-2 diabetes: a prospective twin study","volume":"56","author":"Vaccarino","year":"2014","journal-title":"J Psychiatr Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckr138","article-title":"Relationship between post-traumatic stress disorder and diabetes among 105,180 asylum seekers in the Netherlands","volume":"22","author":"Agyemang","year":"2012","journal-title":"Eur J Public Health"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S319895","article-title":"A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives","volume":"14","author":"Reed","year":"2021","journal-title":"Diabetes Metab syndrome obesity: Targets Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/ijms26031094","article-title":"Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications","volume":"26","author":"M\u0142ynarska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"crossref","first-page":"644317","DOI":"10.3389\/fneur.2021.644317","article-title":"Agitation and dementia: prevention and treatment strategies in acute and chronic conditions","volume":"12","author":"Carrarini","year":"2021","journal-title":"Front neurology."},{"key":"B16","first-page":"Cd012419","article-title":"Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications","volume":"5","author":"Cross","year":"2020","journal-title":"Cochrane Database systematic Rev"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1016\/j.vhri.2021.04.006","article-title":"Direct medical cost of type 2 diabetes mellitus and its associated complications in Indonesia","volume":"28","author":"Hidayat","year":"2022","journal-title":"Value Health Regional Issues."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2022.02.002","article-title":"2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care","volume":"16","author":"Seidu","year":"2022","journal-title":"Primary Care Diabetes"},{"key":"B19","doi-asserted-by":"crossref","first-page":"107140","DOI":"10.1016\/j.ijid.2024.107140","article-title":"Tuberculosis and diabetes mellitus: The complexity of the comorbid interactions","volume":"146","author":"Boadu","year":"2024","journal-title":"Int J Infect Diseases."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/20523211.2024.2322107","article-title":"A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries","volume":"17","author":"Butt","year":"2024","journal-title":"J Pharm Policy Pract"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/healthcare12141457","article-title":"The interrelationship between diabetes mellitus and emotional well-being: current concepts and future prospects","volume":"12","author":"Mangoulia","year":"2024","journal-title":"Healthcare."},{"key":"B22","article-title":"Study of expression of TLR2, TLR4 and transckription factor NF-kB structures of galt of rats in the conditions of the chronic social stress and modulation of structure of intestinal microflora","author":"Topol","year":"2013","journal-title":"Georgian Med news."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.33263\/BRIAC","article-title":"The cytochrome 11B2 aldosterone synthase gene CYP11B2 (RS1799998) polymorphism associates with chronic kidney disease in hypertensive patients","volume":"10","author":"Dzhuryak","year":"2020","journal-title":"Biointerface Res Appl Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2020-0183","article-title":"Analysis of the transcriptional activity of genes of neuropeptides and their receptors in the blood of patients with thyroid pathology","volume":"14","author":"Kamyshna","year":"2021","journal-title":"J Med Life"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.12998\/wjcc.v11.i14.3128","article-title":"Burden of disability in type 2 diabetes mellitus and the moderating effects of physical activity","volume":"11","author":"Oyewole","year":"2023","journal-title":"World J Clin cases."},{"key":"B26","article-title":"Diabetes is not associated with an increased risk of hepatocellular carcinoma in patients with alcoholic or hepatitis C virus cirrhosis","volume":"113","author":"Rodr\u00edguez-Escaja","year":"2021","journal-title":"Rev espanola enfermedades digestivas."},{"key":"B27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/enr-2021-0002","article-title":"Primary hypothyroidism and autoimmune thyroiditis alter the transcriptional activity of genes regulating neurogenesis in the blood of patients","volume":"55","author":"Bilous","year":"2021","journal-title":"Endocrine regulations."},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1159\/000511002","article-title":"Management of type 2 diabetes: current strategies, unfocussed aspects, challenges, and alternatives","volume":"30","author":"Borse","year":"2021","journal-title":"Med principles practice: Int J Kuwait University Health Sci Centre."},{"key":"B29","doi-asserted-by":"crossref","first-page":"110708","DOI":"10.1016\/j.biopha.2020.110708","article-title":"Type II diabetes mellitus: a review on recent drug based therapeutics","volume":"131","author":"Padhi","year":"2020","journal-title":"Biomedicine Pharmacotherapy."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102436","article-title":"Current advances in the management of diabetes mellitus","volume":"10","author":"Aloke","year":"2022","journal-title":"Biomedicines"},{"key":"B31","doi-asserted-by":"publisher","first-page":"102037","DOI":"10.1016\/j.bbrep.2025.102037","article-title":"Type 2 diabetes mellitus - conventional therapies and future perspectives in innovative treatment","volume":"42","author":"Gieroba","year":"2025","journal-title":"Biochem biophysics Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081630","article-title":"Diabetes and osteoarthritis: exploring the interactions and therapeutic implications of insulin, metformin, and GLP-1-based interventions","volume":"12","author":"Halabitska","year":"2024","journal-title":"Biomedicines."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2012.02.017","article-title":"DPP IV inhibitors: Successes, failures and future prospects","volume":"5","author":"Kshirsagar","year":"2011","journal-title":"Diabetes Metab Syndrome: Clin Res Rev"},{"key":"B34","doi-asserted-by":"crossref","first-page":"155332","DOI":"10.1016\/j.metabol.2022.155332","article-title":"Pharmacotherapy of type 2 diabetes: An update and future directions","volume":"137","author":"DeMarsilis","year":"2022","journal-title":"Metabolism: Clin experimental."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13381","DOI":"10.3390\/ijms241713381","article-title":"Advances in research on type 2 diabetes mellitus targets and therapeutic agents","volume":"24","author":"Su","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1186\/s12879-020-05512-7","article-title":"The epidemiology of tuberculosis-associated hyperglycemia in individuals newly screened for type 2 diabetes mellitus: systematic review and meta-analysis","volume":"20","author":"Menon","year":"2020","journal-title":"BMC Infect diseases."},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.3390\/nu16193349","volume-title":"Exploring the efficacy of alpha-lipoic acid in comorbid osteoarthritis and type 2 diabetes mellitus","author":"Halabitska","year":"2024"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia."},{"key":"B40","doi-asserted-by":"publisher","first-page":"115734","DOI":"10.1016\/j.biopha.2023.115734","article-title":"Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments","volume":"168","author":"Antar","year":"2023","journal-title":"Biomedicine Pharmacotherapy."},{"key":"B41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","article-title":"Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy","volume":"9","author":"Lu","year":"2024","journal-title":"Signal transduction targeted Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"115263","DOI":"10.1016\/j.bmc.2019.115263","article-title":"Anti-diabetic drugs recent approaches and advancements","volume":"28","author":"Dowarah","year":"2020","journal-title":"Bioorganic medicinal Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"27507","DOI":"10.1038\/s41598-024-78878-2","article-title":"Design, synthesis, and evaluation of novel substituted imidazo[1,2-c]quinazoline derivatives as potential \u03b1-glucosidase inhibitors with bioactivity and molecular docking insights","volume":"14","author":"Peytam","year":"2024","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400057","article-title":"A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives","volume":"357","author":"Ghoneim","year":"2024","journal-title":"Archiv der Pharmazie."},{"key":"B45","first-page":"97","article-title":"Chapter Three - Linagliptin: A comprehensive profile","volume-title":"Profiles of drug substances, excipients and related methodology","author":"Kabil","year":"2025"},{"key":"B46","doi-asserted-by":"publisher","first-page":"100207","DOI":"10.1016\/j.ejmcr.2024.100207","article-title":"Design, synthesis, \u03b1-glucosidase inhibition and hypoglycemic activity of 3-aceto(benzo)hydrazide-1,2,4-triazines as potential anti-diabetic agents","volume":"12","author":"Valipour","year":"2024","journal-title":"Eur J Medicinal Chem Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071534","article-title":"Energy metabolism and metformin: effects on ischemia-reperfusion injury in kidney transplantation","volume":"12","author":"Nemeth","year":"2024","journal-title":"Biomedicines."},{"key":"B48","doi-asserted-by":"crossref","first-page":"155223","DOI":"10.1016\/j.metabol.2022.155223","article-title":"Metformin: Is it a drug for all reasons and diseases","volume":"133","author":"Triggle","year":"2022","journal-title":"Metabolism: Clin Exp"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.3390\/ijms23084132","article-title":"Structural comparison of sulfonamide-based derivatives that can improve anti-coagulation properties of metformin","volume":"23","author":"Zajda","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B50","article-title":"Effects of metformin, insulin on hematological parameters of COVID-19 patients with type 2 diabetes","volume":"76","author":"Petakh","year":"2022","journal-title":"Med Arch (Sarajevo Bosnia Herzegovina)."},{"key":"B51","article-title":"Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single ta blet","volume":"4","author":"Halimi","year":"2008","journal-title":"Vasc Health Risk management."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1015045","article-title":"Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"B53","article-title":"Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity","volume":"107","author":"Giri","year":"2018","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ph16060904","article-title":"Metformin therapy changes gut microbiota alpha-diversity in COVID-19 patients with type 2 diabetes: the role of SARS-coV-2 variants and antibiotic treatment","volume":"16","author":"Petakh","year":"2023","journal-title":"Pharm (Basel Switzerland)."},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1038\/s41598-019-42531-0","article-title":"Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport","volume":"9","author":"Horakova","year":"2019","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2020-0029","article-title":"The influence of metformin to the transcriptional activity of the mTOR and FOX3 genes in parapancreatic adipose tissue of streptozotocin-induced diabetic rats","volume":"13","author":"Putilin","year":"2020","journal-title":"J Med Life"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3390\/v16121938","article-title":"Metformin in antiviral therapy: evidence and perspectives","volume":"16","author":"Halabitska","year":"2024","journal-title":"Viruses."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S409373","article-title":"Metformin: A review of potential mechanism and therapeutic utility beyond diabetes","volume":"17","author":"Dutta","year":"2023","journal-title":"Drug design Dev Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1330797","article-title":"Examining the clinical relevance of metformin as an antioxidant intervention","volume":"15","author":"Buczy\u0144ska","year":"2024","journal-title":"Front Pharmacol"},{"key":"B62","first-page":"57","article-title":"Metformin in cancer prevention and therapy","volume":"2","author":"Kasznicki","year":"2014","journal-title":"Ann Trans Med"},{"key":"B63","doi-asserted-by":"crossref","first-page":"101805","DOI":"10.1016\/j.molmet.2023.101805","article-title":"Effects of metformin on the gut microbiota: A systematic review","volume":"77","author":"Pavlo","year":"2023","journal-title":"Mol Metab"},{"key":"B64","doi-asserted-by":"crossref","first-page":"112230","DOI":"10.1016\/j.biopha.2021.112230","article-title":"Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential","volume":"144","author":"Kamyshnyi","year":"2021","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S200059","article-title":"The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances","volume":"11","author":"Saraei","year":"2019","journal-title":"Cancer Manage Res"},{"key":"B66","doi-asserted-by":"crossref","first-page":"114892","DOI":"10.1016\/j.biopha.2023.114892","article-title":"The F\/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin","volume":"163","author":"Petakh","year":"2023","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1567544","article-title":"Metformin as a disease-modifying therapy in osteoarthritis: bridging metabolism and joint health","volume":"16","author":"Halabitska","year":"2025","journal-title":"Front Pharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00623-8","article-title":"Persistent physical symptoms: definition, genesis, and management","volume":"403","author":"L\u00f6we","year":"2024","journal-title":"Lancet"},{"key":"B69","article-title":"Case report: Diagnostic reconceptualization in the DSM-V on somatoform disorders","volume":"17","author":"Ibarra-Patr\u00f3n","year":"2015","journal-title":"Med Universitaria."},{"key":"B70","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/antiox13050504","article-title":"Modulating nitric oxide: implications for cytotoxicity and cytoprotection","volume":"13","author":"Belenichev","year":"2024","journal-title":"Antioxidants."},{"key":"B71","first-page":"39","article-title":"Expression levels of proinflammatory cytokines and NLRP3 inflammasome in an experimental model of oxazolone-induced colitis","volume":"15","author":"Zherebiatiev","year":"2016","journal-title":"Iranian J allergy asthma Immunol"},{"key":"B72","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/ph18040486","article-title":"Overview of metformin and neurodegeneration: A comprehensive review","volume":"18","author":"Kruczkowska","year":"2025","journal-title":"Pharmaceuticals."},{"key":"B73","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat Rev Endocrinology."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/cplu.201500051","article-title":"2-heteroaryl-[1,2,4]triazolo[1,5-c]quinazoline-5(6\u2009H)-thiones and their S-substituted derivatives: synthesis, spectroscopic data, and biological activity","volume":"80","author":"Bilyi","year":"2015","journal-title":"ChemPlusChem."},{"key":"B75","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3797\/scipharm.1402-10","article-title":"Synthesis and antimicrobial activity of 6-thioxo-6,7-dihydro-2H-[1,2,4]triazino[2,3-c]-quinazolin-2-one derivatives","volume":"82","author":"Nosulenko","year":"2014","journal-title":"Scientia pharmaceutica."},{"key":"B76","doi-asserted-by":"publisher","first-page":"138289","DOI":"10.1016\/j.molstruc.2024.138289","article-title":"Efficient synthesis and molecular docking analysis of quinazoline and azole hybrid derivatives as promising agents for anti-cancer and anti-tuberculosis activities","volume":"1310","author":"Kumar","year":"2024","journal-title":"J Mol Struct"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/ph17111437","article-title":"Bioisosteric replacement in the search for biologically active compounds: design, synthesis and anti-inflammatory activity of novel [1,2,4]triazino[2,3-c]quinazolines","volume":"17","author":"Grytsak","year":"2024","journal-title":"Pharmaceuticals."},{"key":"B78","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/biom9100551","article-title":"Antidiabetic potential of medicinal plants and their active components","volume":"9","author":"Salehi","year":"2019","journal-title":"Biomolecules"},{"key":"B79","doi-asserted-by":"publisher","first-page":"100189","DOI":"10.1016\/j.ejmcr.2024.100189","article-title":"Exploring the therapeutic potential of xanthones in diabetes management: Current insights and future directions","volume":"12","author":"Saikia","year":"2024","journal-title":"Eur J Medicinal Chem Rep"},{"key":"B80","doi-asserted-by":"crossref","first-page":"1130625","DOI":"10.3389\/fmolb.2023.1130625","article-title":"DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature","volume":"10","author":"Saini","year":"2023","journal-title":"Front Mol biosciences."},{"key":"B81","doi-asserted-by":"crossref","first-page":"112957","DOI":"10.1016\/j.biopha.2022.112957","article-title":"Update of Indoles: Promising molecules for ameliorating metabolic diseases","volume":"150","author":"Hu","year":"2022","journal-title":"Biomedicine Pharmacotherapy."},{"key":"B82","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s10593-017-2142-5","article-title":"1,2,4]Triazino[2,3-\u0441]quinazolines 1. Methods for the preparation and spectral characteristics of substituted 3-R1-6-R3-6,7-dihydro-2H-[1,2,4]triazino[2,3-\u0441]quinazolin-2-ones","volume":"53","author":"Voskoboynik","year":"2017","journal-title":"Chem Heterocyclic Compounds."},{"key":"B83","doi-asserted-by":"crossref","DOI":"10.1007\/s10593-017-2184-8","article-title":"1,2,4]Triazino[2,3-\u0441]quinazolines 2*. Synthesis, structure, and anticonvulsant activity of new 3\u2032-R1-spiro[(aza\/oxa\/thia)cycloalkyl-1(3, 4),6\u2032-[1,2,4]triazino[2,3-c]quinazolin]-2\u2032(7\u2032H)-ones","volume":"53","author":"Voskoboynik","year":"2017","journal-title":"Chem Heterocyclic Compounds."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.3862","article-title":"Tandem heterocyclization of 2-(azolyl-(azinyl-))anilines as an efficient method for preparation of substituted pyrrolo[1,2-a]azolo-(azino-)[c]quinazolines","volume":"57","author":"Stavytskyi","year":"2020","journal-title":"J Heterocyclic Chem"},{"key":"B85","doi-asserted-by":"publisher","first-page":"25","DOI":"10.24959\/ophcj.15.817","article-title":"Peculiarites of interaction between 3-(2-aminophenyl)-6-R-1,2,4-triazin-5(2H)-ones and cyclic anhydrides of non-symmetric dicarboxylic acids","volume":"13","author":"Voskoboynik","year":"2015","journal-title":"J Organic Pharm Chem"},{"key":"B86","first-page":"03","volume-title":"European convention for the protection of vertebrate animals used for experimental and other scientific purposes","year":"1986"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1992.tb01813.x","article-title":"The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp","volume":"9","author":"Akinmokun","year":"1992","journal-title":"Diabetic medicine: J Br Diabetic Assoc"},{"key":"B88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0026-0495(98)90184-6","article-title":"Dexamethasone inhibits insulin-stimulated recruitment of GLUt4 to the cell surface in rat skeletal muscle","volume":"47","author":"Weinstein","year":"1998","journal-title":"Metab - Clin Experimental."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac087","article-title":"FitDock: protein-ligand docking by template fitting","volume":"23","author":"Yang","year":"2022","journal-title":"Briefings Bioinf"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.554961","article-title":"Multi-target approaches in metabolic syndrome","volume":"11","author":"Lillich","year":"2020","journal-title":"Front Pharmacol"},{"key":"B92","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/978-981-96-4154-3_21","article-title":"Advances in the design of novel antidiabetic agents using in-silico approaches","volume-title":"Applications of computational tools in drug design and development","author":"Jadhav","year":"2025"},{"key":"B93","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/biomedicines12071386","article-title":"Novel Therapeutics for Type 2 Diabetes Mellitus\u2014A Look at the Past Decade and a Glimpse into the Future","volume":"12","author":"Chee","year":"2024","journal-title":"Biomedicines."},{"key":"B94","article-title":"Pathophysiology of diabetes: An overview","volume":"10","author":"Banday","year":"2020","journal-title":"Avicenna J Med"},{"key":"B95","doi-asserted-by":"crossref","first-page":"2042018820980225","DOI":"10.1177\/2042018820980225","article-title":"Should metformin remain the first-line therapy for treatment of type 2 diabetes","volume":"12","author":"Baker","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr1409796","article-title":"The target of metformin in type 2 diabetes","volume":"371","author":"Ferrannini","year":"2014","journal-title":"New Engl J Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/dom.15729","article-title":"Clinical efficacy and cost-effectiveness of metformin in different patient populations: A narrative review of real-world evidence","author":"Solini","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01406-6","article-title":"Narrative review of data supporting alternate first-line therapies over metformin in type 2 diabetes","volume":"23","author":"Andraos","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030312","article-title":"Metformin: A narrative review of its potential benefits for cardiovascular disease, cancer and dementia","volume":"15","author":"Top","year":"2022","journal-title":"Pharm (Basel Switzerland)."},{"key":"B100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-8587(23)00316-9","article-title":"Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial","volume":"12","author":"Ray","year":"2024","journal-title":"Lancet Diabetes Endocrinology."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1022739","article-title":"Metformin: Activation of 5\u2019 AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action","volume":"13","author":"Goel","year":"2022","journal-title":"Front Genet"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/ph17040478","article-title":"View on metformin: antidiabetic and pleiotropic effects, pharmacokinetics, side effects, and sex-related differences","volume":"17","author":"Froldi","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B103","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41574-022-00746-8","article-title":"The multiple roles of life stress in metabolic disorders","volume":"19","author":"Kivim\u00e4ki","year":"2023","journal-title":"Nat Rev Endocrinology."},{"key":"B104","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s43556-022-00108-w","article-title":"Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study","volume":"3","author":"Du","year":"2022","journal-title":"Mol biomedicine."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.622262","article-title":"Metformin: A novel weapon against inflammation","volume":"12","author":"Bai","year":"2021","journal-title":"Front Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1185080","article-title":"Editorial: Role of gut microbiota in diabetes mellitus and tumor immunity","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41559","article-title":"Understanding the role of the gut microbiome in diabetes and therapeutics targeting leaky gut: A systematic review","volume":"15","author":"Sadagopan","year":"2023","journal-title":"Cureus."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70168","article-title":"Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10030578","article-title":"Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options","volume":"10","author":"Hrncir","year":"2022","journal-title":"Microorganisms"},{"key":"B110","doi-asserted-by":"publisher","first-page":"9715","DOI":"10.3390\/ijms25179715","article-title":"Insights into gut dysbiosis: inflammatory diseases, obesity, and restoration approaches","volume":"25","author":"Acevedo-Rom\u00e1n","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B111","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00018-024-05476-w","article-title":"The interplay of gut microbiota, obesity, and depression: insights and interventions","volume":"81","author":"Halabitska","year":"2024","journal-title":"Cell Mol Life sciences: CMLS."},{"key":"B112","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/ph18010055","article-title":"The gut microbiota-related antihyperglycemic effect of metformin","volume":"18","author":"Szymczak-Pajor","year":"2025","journal-title":"Pharmaceuticals."},{"key":"B113","doi-asserted-by":"crossref","first-page":"905171","DOI":"10.3389\/fendo.2022.905171","article-title":"Effects of oral glucose-lowering agents on gut microbiota and microbial metabolites","volume":"13","author":"Wang","year":"2022","journal-title":"Front endocrinology."},{"key":"B114","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s44337-025-00241-9","article-title":"Exploring the impact of type 2 diabetes and glucose-lowering drugs on gut microbiome dynamics","volume":"2","author":"Tariq","year":"2025","journal-title":"Discover Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16105","article-title":"The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes","volume":"288","author":"Tong","year":"2021","journal-title":"FEBS J"},{"key":"B116","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1186\/s12879-025-11089-w","article-title":"Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 - a systematic review and meta-analyses","volume":"25","author":"Fatoke","year":"2025","journal-title":"BMC Infect diseases."},{"key":"B117","doi-asserted-by":"crossref","first-page":"107809","DOI":"10.1016\/j.jdiacomp.2020.107809","article-title":"Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus","volume":"35","author":"Cheng","year":"2021","journal-title":"J Diabetes its complications."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.732913","article-title":"Immunometabolic dysregulation at the intersection of obesity and COVID-19","volume":"12","author":"Khwatenge","year":"2021","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.09.006","article-title":"SARS-CoV-2 in immunocompromised individuals","volume":"55","author":"DeWolf","year":"2022","journal-title":"Immunity."},{"key":"B120","doi-asserted-by":"crossref","DOI":"10.1007\/s12192-023-01379-0","article-title":"SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway","volume":"28","author":"Hamad","year":"2023","journal-title":"Cell Stress Chaperones."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/biom12121830","article-title":"Weil\u2019s disease-immunopathogenesis, multiple organ failure, and potential role of gut microbiota","volume":"12","author":"Petakh","year":"2022","journal-title":"Biomolecules."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.973587","article-title":"Cytokine storm-calming property of the isoquinoline alkaloids in Coptis chinensis Franch","volume":"13","author":"Lan","year":"2022","journal-title":"Front Pharmacol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/ph18010104","article-title":"Targeting cytokine-mediated inflammation in brain disorders: developing new treatment strategies","volume":"18","author":"Mallick","year":"2025","journal-title":"Pharmaceuticals."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed9010013","article-title":"Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: A comprehensive review","volume":"9","author":"Al-Qahtani","year":"2024","journal-title":"Trop Med Infect Dis"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/v16060985","article-title":"Modulatory roles of AHR, FFAR2, FXR, and TGR5 gene expression in metabolic-associated fatty liver disease and COVID-19 outcomes","volume":"16","author":"Buchynskyi","year":"2024","journal-title":"Viruses."},{"key":"B126","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1038\/s41467-023-43304-0","article-title":"Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis","volume":"14","author":"Parveen","year":"2023","journal-title":"Nat Commun"},{"key":"B127","doi-asserted-by":"crossref","first-page":"101400","DOI":"10.1016\/j.mtbio.2024.101400","article-title":"Metal-phenolic network biointerface-mediated cell regulation for bone tissue regeneration","volume":"30","author":"Wang","year":"2025","journal-title":"Materials Today Bio."},{"key":"B128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41419-025-07583-3","article-title":"Mechanisms and therapeutic opportunities in metabolic aberrations of diabetic wounds: a narrative review","volume":"16","author":"Xiong","year":"2025","journal-title":"Cell Death disease."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3390\/biom15030414","article-title":"Distinct roles of common genetic variants and their contributions to diabetes: MODY and uncontrolled T2DM","volume":"15","author":"Bazzazzadehgan","year":"2025","journal-title":"Biomolecules."},{"key":"B131","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/dci21-0051","article-title":"Heterogeneity of diabetes: \u03b2-cells, phenotypes, and precision medicine: proceedings of an international symposium of the canadian institutes of health research\u2019s institute of nutrition, metabolism and diabetes and the U.S. National institutes of health\u2019s national institute of diabetes and digestive and kidney diseases","volume":"45","author":"Cefalu","year":"2022","journal-title":"Diabetes Care"},{"key":"B132","doi-asserted-by":"crossref","DOI":"10.4239\/wjd.v7.i15.302","article-title":"Pharmacogenetic studies update in type 2 diabetes mellitus","volume":"7","author":"Singh","year":"2016","journal-title":"World J diabetes."},{"key":"B133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/diabetology6020011","article-title":"Genetic susceptibility of type 2 diabetes and metabolic syndrome","volume":"6","author":"Ercegovi\u0107","year":"2025","journal-title":"Diabetology."},{"key":"B134","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1475-2840-11-133","article-title":"Single nucleotide polymorphisms (SNPs) involved in insulin resistance, weight regulation, lipid metabolism and inflammation in relation to metabolic syndrome: an epidemiological study","volume":"11","author":"Povel","year":"2012","journal-title":"Cardiovasc diabetology."},{"key":"B135","doi-asserted-by":"crossref","first-page":"1399694","DOI":"10.3389\/fendo.2024.1399694","article-title":"Genetic and inflammatory factors underlying gestational diabetes mellitus: a review","volume":"15","author":"Ray","year":"2024","journal-title":"Front endocrinology."},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1460318","article-title":"Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study","volume":"15","author":"Buchynskyi","year":"2024","journal-title":"Front Genet"},{"key":"B137","doi-asserted-by":"crossref","first-page":"25","DOI":"10.36740\/WLek202001104","article-title":"SNPs and transcriptional activity of genes of innate and adaptive immunity at the maternal-fetal interface in woman with preterm labour, associated with preterm premature rupture of membranes","volume":"73","author":"Lyubomirskaya","year":"2020","journal-title":"Wiadomosci lekarskie (Warsaw Poland: 1960)."},{"key":"B138","article-title":"Understanding the genetic basis of type 2 diabetes: implications for precision medicine and novel therapeutic approaches","volume":"3","author":"Joya","year":"2025","journal-title":"Indus J Bioscience Res"},{"key":"B139","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/genes16050578","article-title":"Gene\u2013diet interactions in diabetes mellitus: current insights and the potential of personalized nutrition","volume":"16","author":"Kapellou","year":"2025","journal-title":"Genes."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1416924","article-title":"Genetic insights and emerging therapeutics in diabetic retinopathy: from molecular pathways to personalized medicine","volume":"15","author":"Pei","year":"2024","journal-title":"Front Genet"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086887","article-title":"Therapeutic effectiveness of interferon-\u03b12b against COVID-19 with community-acquired pneumonia: the ukrainian experience","volume":"24","author":"Kamyshnyi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1403765","article-title":"Current treatment options for leptospirosis: a mini-review","volume":"15","author":"Petakh","year":"2024","journal-title":"Front Microbiol"},{"key":"B143","doi-asserted-by":"crossref","first-page":"38","DOI":"10.15407\/fz60.02.038","article-title":"Expression of XBP1 in lymphocytes of the small intestine in rats under chronic social stress and modulation of intestinal microflora composition","volume":"60","author":"Topol","year":"2014","journal-title":"Fiziolohichnyi zhurnal (Kiev Ukraine: 1994)."},{"key":"B144","doi-asserted-by":"publisher","first-page":"9677","DOI":"10.3390\/ijms24119677","article-title":"Type 2 diabetes mellitus, non-alcoholic fatty liver disease, and metabolic repercussions: the vicious cycle and its interplay with inflammation","volume":"24","author":"Frankowski","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B145","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s43045-023-00340-2","article-title":"Prevalence and correlates of stress, anxiety, and depression in patients with chronic diseases: a cross-sectional study","volume":"30","author":"Vadakkiniath","year":"2023","journal-title":"Middle East Curr Psychiatry"},{"key":"B146","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/jcm14020428","article-title":"The triad of risk: linking MASLD, cardiovascular disease and type 2 diabetes; from pathophysiology to treatment","volume":"14","author":"Michalopoulou","year":"2025","journal-title":"J Clin Med"},{"key":"B147","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12902-023-01515-y","article-title":"Glycemic control and associated factors among type 2 diabetes mellitus patients: a cross-sectional study of Azar cohort population","volume":"23","author":"Dinavari","year":"2023","journal-title":"BMC endocrine Disord"},{"key":"B148","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41398-025-03234-5","article-title":"The interface of depression and diabetes: treatment considerations","volume":"15","author":"Fanelli","year":"2025","journal-title":"Trans Psychiatry"},{"key":"B149","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.gloepi.2023.100113","article-title":"Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: A cross-sectional study","volume":"5","author":"Suprapti","year":"2023","journal-title":"Global Epidemiol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01199-8","article-title":"Evaluation of the clinical and economic burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the United States","volume":"37","author":"Ali","year":"2020","journal-title":"Adv Ther"},{"key":"B151","article-title":"The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios","volume":"7","author":"McGill","year":"2017","journal-title":"J Clin Trans endocrinology."},{"key":"B152","doi-asserted-by":"publisher","first-page":"12127","DOI":"10.1038\/s41598-025-97416-2","article-title":"Identification and validation of five novel protein targets for type 2 diabetes mellitus","volume":"15","author":"Tao","year":"2025","journal-title":"Sci Rep"},{"key":"B153","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.3390\/ijms26104578","article-title":"Active constituent of HQS in T2DM intervention: efficacy and mechanistic insights","volume":"26","author":"Chen","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"102412","DOI":"10.1016\/j.omtn.2024.102412","article-title":"RNA splicing variants of the novel long non-coding RNA, CyKILR, possess divergent biological functions in non-small cell lung cancer","volume":"36","author":"Xie","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"B155","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.3390\/ijms26094445","article-title":"Precise electromagnetic modulation of the cell cycle and its applications in cancer therapy","volume":"26","author":"Shi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.349","article-title":"Signaling pathways in macrophages: molecular mechanisms and therapeutic targets","volume":"4","author":"Li","year":"2023","journal-title":"MedComm."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062188","article-title":"Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic","volume":"12","author":"Okdahl","year":"2022","journal-title":"BMJ Open"},{"key":"B158","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.3390\/ijms25073769","article-title":"Immunomodulation through nutrition should be a key trend in type 2 diabetes treatment","volume":"25","author":"Napi\u00f3rkowska-Baran","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.15420\/ecr","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol"},{"key":"B160","doi-asserted-by":"crossref","DOI":"10.3390\/immuno2040038","article-title":"Prevention and treatment of obesity-related inflammatory diseases by edible and medicinal plants and their active compounds","volume":"2","author":"Saad","year":"2022","journal-title":"Immuno."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e1834","DOI":"10.1002\/hsr2.1834","article-title":"Predictive model for early detection of type 2 diabetes using patients\u2019 clinical symptoms, demographic features, and knowledge of diabetes","volume":"7","author":"Ojurongbe","year":"2024","journal-title":"Health Sci Rep"},{"key":"B162","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/ijerph18020716","article-title":"Bisphenol A and type 2 diabetes mellitus: A review of epidemiologic, functional, and early life factors","volume":"18","author":"Farrugia","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B163","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1463-1326.1999.00014.x","article-title":"In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery","volume":"1","author":"Reed","year":"1999","journal-title":"Diabetes Obes Metab"},{"key":"B164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cpan.2024.11.001","article-title":"Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies","volume":"21","author":"Chen","year":"2024","journal-title":"Curr Pharm Analysis."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.3390\/ijms26062703","article-title":"Drug discovery and development for heart failure using multi-omics approaches","volume":"26","author":"Rasooly","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B166","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal transduction targeted Ther"},{"key":"B167","doi-asserted-by":"publisher","first-page":"114784","DOI":"10.1016\/j.biopha.2023.114784","article-title":"Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology","volume":"163","author":"Singh","year":"2023","journal-title":"Biomedicine Pharmacotherapy."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/medicina61061003","article-title":"Neuroimaging insights into the public health burden of neuropsychiatric disorders: A systematic review of electroencephalography-based cognitive biomarkers","volume":"61","author":"Gkintoni","year":"2025","journal-title":"Medicina."},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3390\/ph18040555","article-title":"The emergence of psilocybin in psychiatry and neuroscience","volume":"18","author":"Omidian","year":"2025","journal-title":"Pharm (Basel Switzerland)."},{"key":"B170","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41398-022-02254-9","article-title":"Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study","volume":"12","author":"Sauder","year":"2022","journal-title":"Transl Psychiatry"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1638013\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:12:22Z","timestamp":1758168742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1638013\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":170,"alternative-id":["10.3389\/fendo.2025.1638013"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1638013","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"1638013"}}